DK1756316T3 - Humant fedmetilbøjelighedsgen kodende for en spændingsstyret kaliumkanal og anvendelser deraf - Google Patents

Humant fedmetilbøjelighedsgen kodende for en spændingsstyret kaliumkanal og anvendelser deraf

Info

Publication number
DK1756316T3
DK1756316T3 DK05764662.2T DK05764662T DK1756316T3 DK 1756316 T3 DK1756316 T3 DK 1756316T3 DK 05764662 T DK05764662 T DK 05764662T DK 1756316 T3 DK1756316 T3 DK 1756316T3
Authority
DK
Denmark
Prior art keywords
obesity
applications
voltage
gene encoding
gene
Prior art date
Application number
DK05764662.2T
Other languages
English (en)
Inventor
Anne Philippi
Francis Rousseau
Elke Roschmann
Original Assignee
Integragen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integragen Sa filed Critical Integragen Sa
Application granted granted Critical
Publication of DK1756316T3 publication Critical patent/DK1756316T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Electrotherapy Devices (AREA)
  • Eye Examination Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05764662.2T 2004-06-14 2005-06-14 Humant fedmetilbøjelighedsgen kodende for en spændingsstyret kaliumkanal og anvendelser deraf DK1756316T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57882904P 2004-06-14 2004-06-14
PCT/IB2005/002356 WO2005123949A2 (en) 2004-06-14 2005-06-14 Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof

Publications (1)

Publication Number Publication Date
DK1756316T3 true DK1756316T3 (da) 2010-01-18

Family

ID=35395853

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05764662.2T DK1756316T3 (da) 2004-06-14 2005-06-14 Humant fedmetilbøjelighedsgen kodende for en spændingsstyret kaliumkanal og anvendelser deraf

Country Status (10)

Country Link
US (1) US20080193923A1 (da)
EP (1) EP1756316B1 (da)
JP (1) JP2008502341A (da)
AT (1) ATE443160T1 (da)
AU (1) AU2005254806B2 (da)
CA (1) CA2568957A1 (da)
DE (1) DE602005016676D1 (da)
DK (1) DK1756316T3 (da)
IL (1) IL179744A0 (da)
WO (1) WO2005123949A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113671179B (zh) * 2021-09-02 2023-10-03 中国科学院深圳先进技术研究院 一种kcnab2自身抗体的检测用试剂盒及其检测方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252922A (en) * 1991-04-30 1993-10-12 Hewlett-Packard Company Radiofrequency focusing of magnetic resonance images
US5221900A (en) * 1991-04-30 1993-06-22 Hewlett-Packard Company Magnet structure for focusing of magnetic resonance images
US5185573A (en) * 1991-04-16 1993-02-09 Hewlett-Packard Company Method for focusing of magnetic resonance images
US6477398B1 (en) * 1997-11-13 2002-11-05 Randell L. Mills Resonant magnetic susceptibility imaging (ReMSI)
AU2001245489A1 (en) * 2000-03-07 2001-09-17 Whitehead Institute For Biomedical Research Human single nucleotide polymorphisms
US6682888B1 (en) * 2000-05-05 2004-01-27 Incyte Corporation Genes expressed in alzheimer's disease
WO2002028999A2 (en) * 2000-10-03 2002-04-11 Gene Logic, Inc. Gene expression profiles in granulocytic cells
WO2004035755A2 (en) * 2002-10-16 2004-04-29 Incyte Corporation Transporters and ion channels

Also Published As

Publication number Publication date
EP1756316A2 (en) 2007-02-28
AU2005254806B2 (en) 2009-06-04
WO2005123949A2 (en) 2005-12-29
ATE443160T1 (de) 2009-10-15
EP1756316B1 (en) 2009-09-16
IL179744A0 (en) 2007-05-15
JP2008502341A (ja) 2008-01-31
US20080193923A1 (en) 2008-08-14
CA2568957A1 (en) 2005-12-29
DE602005016676D1 (de) 2009-10-29
WO2005123949A3 (en) 2006-03-16
AU2005254806A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
Milaneschi et al. Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations
Carrasquillo et al. Replication of CLU, CR1, and PICALM associations with alzheimer disease
Ghani et al. Association of long runs of homozygosity with Alzheimer disease among African American individuals
DE602005004026D1 (de) Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen
MX2021010988A (es) Derivados de insulina sensibles a la glucosa.
WO2006087634A3 (en) Uses of human autism susceptibility gene encoding a kinase
Penfold et al. Pediatric uptake of a newly available antipsychotic medication
DK1761650T3 (da) Humant autisme modtagelighedsgen, der koder for PRKCB1 og anvendelser deraf
Bellini Cited or read?
DK1756316T3 (da) Humant fedmetilbøjelighedsgen kodende for en spændingsstyret kaliumkanal og anvendelser deraf
DK1504125T3 (da) Humant fedmemodtagelighedsgen og anvendelser deraf
DK1863937T3 (da) Humant autisme-susceptibilitetsgen kodende for et transmembranprotein og anvendelser deraf
Vij et al. Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.
Cox ‘recovery from chronic fatigue syndrome after treatments given in the PACE trial’: Data on the recovery groups as a whole would be useful
WO2005021787A3 (en) Human obesity susceptibility gene and uses thereof
WO2005090600A3 (en) Human obesity susceptibility genes encoding peptide hormones and uses thereof
Kubarieva et al. Marketing investigation of preventive therapy of patients with multiple sclerosis
Makaryan et al. Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, ELANE
Wolthers et al. Common Genetic Variants in Trypsin Regulating Genes Are Associated with AsparAginase-Associated Pancreatitis in Children with Acute Lymphoblastic Leukemia: A Ponte Di Legno Toxicity Working Group Study
Ramoz QT length during methadone maintenance treatment: Gene x dose interaction
Whitfield et al. The Benefits of Chlorine Chemistry in Pharmaceuticals in the United States and Canada
ATE374260T1 (de) Asthma-assoziiertes gen
Lebbos et al. Drotrecogin alpha (activated)
Lin et al. Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors
Feld-Glazman et al. Poster 87 The impact of a stroke education program on Patient's stroke knowledge and their change of stroke risk behaviors